Geneos Wealth Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-646
| Closed | -$141K | – | 3204 |
|
|
2021
Q1 | $141K | Hold |
646
| – | – | ﹤0.01% | 1143 |
|
|
2020
Q4 | $95K | Sell |
646
-205
| -24% | -$23K | ﹤0.01% | 1170 |
|
|
2020
Q3 | $85K | Hold |
851
| – | – | ﹤0.01% | 1020 |
|
|
2020
Q2 | $102K | Buy |
851
+80
| +10% | +$9.08K | 0.01% | 911 |
|
|
2020
Q1 | $66K | Sell |
771
-80
| -9% | -$8.47K | ﹤0.01% | 1006 |
|
|
2019
Q4 | $85K | Buy |
851
+50
| +6% | +$5.61K | ﹤0.01% | 1014 |
|
|
2019
Q3 | $93K | Buy |
801
+45
| +6% | +$6.83K | 0.01% | 918 |
|
|
2019
Q2 | $130K | Hold |
756
| – | – | 0.01% | 818 |
|
|
2019
Q1 | $127K | Sell |
756
-35
| -4% | -$5.21K | 0.01% | 782 |
|
|
2018
Q4 | $75K | Buy |
791
+470
| +146% | +$61.7K | 0.01% | 934 |
|
|
2018
Q3 | $55K | Sell |
321
-18
| -5% | -$2.6K | ﹤0.01% | 1138 |
|
|
2018
Q2 | $47K | Sell |
339
-2
| -0.6% | -$284 | ﹤0.01% | 1084 |
|
|
2018
Q1 | $38K | Buy |
341
+152
| +80% | +$19.1K | ﹤0.01% | 1134 |
|
|
2017
Q4 | $24K | Buy |
189
+40
| +27% | +$4.7K | ﹤0.01% | 1317 |
|
|
2017
Q3 | $15K | Sell |
149
-25
| -14% | -$2.68K | ﹤0.01% | 1442 |
|
|
2017
Q2 | $17K | Sell |
174
-265
| -60% | -$28.5K | ﹤0.01% | 1354 |
|
|
2017
Q1 | $53K | Buy |
439
+59
| +16% | +$7.24K | 0.01% | 867 |
|
|
2016
Q4 | $42K | Buy |
380
+16
| +4% | +$1.93K | 0.01% | 905 |
|
|
2016
Q3 | $48K | Buy |
364
+25
| +7% | +$2.39K | 0.01% | 831 |
|
|
2016
Q2 | $31K | Buy |
339
+181
| +115% | +$15.2K | ﹤0.01% | 977 |
|
|
2016
Q1 | $11K | Buy |
+158
| New | +$8.67K | ﹤0.01% | 1292 |
|
Other funds holding GWPH
Geneos Wealth Management's GWPH Position: Q2 2021 in Review
Geneos Wealth Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 646 shares — an estimated $141K sold.
Geneos Wealth Management first reported a position in GWPH in Q1 2016 and held it in 21 quarters. The position peaked at $141K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Geneos Wealth Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Geneos Wealth Management sold 646 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $141K.
- Geneos Wealth Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2016 and held it in 21 quarters.
- Geneos Wealth Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $141K in Q1 2021.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Geneos Wealth Management's 13F filing for Q2 2021, filed 8 Jul 2021.